PRESS RELEASES

 

EPIVAX ANNOUNCES LICENSING OF COVID-19 VACCINE CANDIDATE TO EPIVAX THERAPEUTICS

Aug 25, 2020

This is your News Article. It’s a great place to update your visitors about industry news, or publish relevant announcements about your company. Been in the press recently? Don’t keep it to yourself! Let visitors know about it, and add a link to the original article or write-up.

Subscribe Form

  • LinkedIn

©2020 by EpiVax Therapeutics, Inc.